$27.59 0.5%
AORT Stock Price vs. AI Score
Data gathered: November 5

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Artivion

Artivion Inc. manufactures, processes and distributes implantable human tissues and medical devices worldwide.


Artivion
Price $27.59
Target Price Sign up
Volume 12,540
Market Cap $1.12B
Year Range $18.58 - $28.46
Dividend Yield 0%
Analyst Rating 100% buy
Earnings Date November 7 '24
Industry Medical Devices

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q2 '2498M88M63M-2.1M9.8M-0.050
Q1 '2486M69M63M7.5M25M0.060
Q4 '2390M86M61M-4M9.5M-0.100
Q3 '2381M87M56M-9.8M1.1M-0.240
Q2 '2383M93M58M-3.4M7.6M-0.070

Insider Transactions View All

Horton Amy filed to sell 139,989 shares at $26.2.
October 2 '24
Holloway Jean F filed to sell 161,932 shares at $26.6.
August 27 '24
Getz Matthew A filed to sell 34,116 shares at $25.3.
August 19 '24
Getz Matthew A filed to sell 36,678 shares at $25.3.
August 19 '24
Holloway Jean F filed to sell 165,099 shares at $25.8.
August 16 '24

Congress Trading View All

Politician Filing Date Type Size
Christine Smith
Democrat
Nov 20, 23 Buy $50K - $100K
Christine Smith
Democrat
Nov 20, 23 Buy $50K - $100K
Joshua Gottheimer
Democrat
Aug 21, 23 Buy $1K - $15K

What is the Market Cap of Artivion?

The Market Cap of Artivion is $1.12B.

When does Artivion report earnings?

Artivion will report its next earnings on November 7 '24.

What is the current stock price of Artivion?

Currently, the price of one share of Artivion stock is $27.59.

How can I analyze the AORT stock price chart for investment decisions?

The AORT stock price chart above provides a comprehensive visual representation of Artivion's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Artivion shares. Our platform offers an up-to-date AORT stock price chart, along with technical data analysis and alternative data insights.

Does AORT offer dividends to its shareholders?

As of our latest update, Artivion (AORT) does not offer dividends to its shareholders. Investors interested in Artivion should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Artivion?

Some of the similar stocks of Artivion are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.